The year is 2025, and the landscape of pharmaceutical research has been irrevocably transformed. AI-driven drug discovery is no longer a futuristic concept; it is an integral part of the
The landscape of rare disease treatment has undergone a remarkable transformation in 2025, with CRISPR therapy emerging as a beacon of hope for millions of patients worldwide suffering from orphan